Stay Connected.Sign up to receive the latest news and announcements
JUNE 15, 2022
Medical Funding Professionals (MFP) is pleased to announce that Facible Biodagnostics has engaged MFP to implement the Capital Planning Valuation Strategy™ Co-Chaired by Scott Pantel of LSI and Stephen Brock of MFP in preparation of the company’s Regulation A+ offering.
APRIL 1, 2021
Facible Biodiagnostics announces an additional $521,000 award from The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech initiative.
DECEMBER 15, 2020
Facible Biodiagnostics, a purpose-driven startup company focused on creating fast, accurate and affordable hospital-grade biodiagnostic tests, today announced a $250,000 award from The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech initiative.
Stay Connected.Sign up to receive the latest news and announcements
Facible Biodiagnostics, LLC
366 SW 5th Ave Suite 104
Meridian ID 83642
